Cite
HARVARD Citation
Gregersen, H. et al. (2022). Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group. European journal of haematology. pp. 34-44. [Online].